Equi-Tox, Inc. – Trademark Portfolio

Entity Type: 03

Equi-Tox, Inc. has 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include EQUIDONE. The portfolio includes 1 registered trademark. Filings span 3 Nice Classification classes, led by Class 42 (Computer & Scientific) and Class 9 (Computers & Electronics). This trademark owner is based in Central, SC.

112 Central Road

Central, SC 29630

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Equi-Tox, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Equi-Tox, Inc. have?

Equi-Tox, Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 1 cancelled.

What trademark classes does Equi-Tox, Inc. file in?

Equi-Tox, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Equi-Tox, Inc.'s most well-known trademarks?

Equi-Tox, Inc.'s registered trademark portfolio includes well-known marks such as EQUIDONE. These are among 1 currently registered trademark in the portfolio.

What is Equi-Tox, Inc.'s trademark registration success rate?

Equi-Tox, Inc. has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.